Physiologically active peptide and use thereof

Details Physiologically active peptide and use thereof Physiologically active peptide and use thereof

2006-05-16

2006-05-16

Andres, Janet L. (Department: 1646)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S007930, C435S069100, C530S350000, C530S300000

Reexamination Certificate

active

07045299

ABSTRACT:
The present invention intends to provide a novel peptide and use thereof. More particularly, the present invention provides a novel peptide and a DNA encoding the same, a drug comprising the peptide or DNA, a screening method/screening kit for a compound or its salt that promotes or inhibits the activity of the peptide, a compound or its salt obtained by the screening, a drug comprising the compound or its salt, etc.The peptide of the invention and the DNA encoding the same are usable, e.g., for the diagnosis, treatment, prevention, etc. of digestive diseases, etc. Moreover, the peptide of the invention is useful as a reagent for screening a compound or its salt that promotes or inhibits the activity of the protein of the invention.

REFERENCES:
patent: WO 98/46620 (1998-10-01), None
patent: WO 99/06550 (1999-02-01), None
patent: WO 9906550 (1999-02-01), None
patent: WO 99/63088 (1999-12-01), None
patent: WO 00/34334 (2000-06-01), None
patent: WO 00/52022 (2000-09-01), None
patent: WO 00/53753 (2000-09-01), None
patent: WO 00/70049 (2000-11-01), None
patent: WO 00/73454 (2000-12-01), None
patent: WO 00/75327 (2000-12-01), None
patent: WO 01/16309 (2001-03-01), None
patent: WO 01/36465 (2001-05-01), None
Bowie et al., Science 247: 1306-1310, 1990.
Wells, Biochemistry 29:8509-8517, 1990.
Wechselberger et al. “The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes” FEBS Letters 462 (1999): 177-181.
Parker et al. “Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organization and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6” Biochem et Biophys Acta 1491 (2000): 369-375.
Schweitz et al. “MIT1, a black mamba toxin with a new and highly potent activity on intestinal contraction” FEBS Letters 461 (1999): 183-188.
Tatemoto et al. “Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor” Biochemical and Biophysical research communications 251: 471-476 (1998).
Osinski et al. “Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract” Eur. J. Pharmacology 365 (1999): 281-289.
Fujii et al. “Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled receptor FM-3” Jour. Biol. Chem. 275(28): 21068-21074 (2000).

Affiliated with

Also associated with

Rating

Physiologically active peptide and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Physiologically active peptide and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiologically active peptide and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3576291